Production of generic products declined

Published: 2002-04-09 06:59:00

Updated: 2002-04-09 06:59:00

Now that the Ministry of Health and Welfare (MOHW) plans to exclude non-bioequivalence test drugs from the list of insurance covered drugs from May 1, many pharmaceutical firms are pushing forward the products with market potentials since the implementation of a system of separating drug dispensi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK